Publications

Meniscal Allograft Transplantation in the Adolescent Population

Purpose: Traditionally, meniscal allograft transplantation (MAT) has been thought to be contraindicated in skeletally immature patients. This reports the results of MAT performed in an active adolescent population with a minimum of 2-year follow-up.

Summary:

  • 32 patients with a mean age of 15.4 years underwent a MAT procedure (84% lateral, 16% medial)
  • 48% of patients underwent a concomitant procedure – mainly for chondral defects
  • Significant improvements witnessed in KOOS, Lysholm, IKDC subjective, WOMAC pain and function as well as SF-12 scores post-operatively
  • The only functional outcome score that deteriorated over time was the IKDC subjective which was lower at final follow-up than at 2-year follow-up
  • Meniscal reoperation rate was low at 6% and nearly identical to the 6.3% previously reported in adults
  • After MAT, 7 patients underwent 8 further procedures to address chondral disease
  • No revision MAT procedures were required and no growth complications were reported

 

Take Away: With no incidence of revision MAT, growth complications or perioperative complications MAT is a viable option for adolescents with meniscal insufficiency. The authors are confident that the increased activity level in adolescents in not a contraindication to MAT.

 

Authors: Jonathan C. Riboh, MD, Annemarie K. Tilton, BS, Gregory L. Cvetanovich, MD, Kirk A. Campbell, MD and Brian J. Cole, MD, MBA

Published: "Meniscal Allograft Transplantation in the Adolescent Population". Arthroscopy. 2016 Jun;32(6):1133-1140.

Institution: Division of Sports Medicine, Rush University Medical Center

Click here to access the abstract.

✅ Your Privacy Choice Has Been HonoredWe detected your opt-out preference signal (such as Global Privacy Control) and have honored your request. JRF Ortho will not sell or share your personal information for targeted advertising purposes during this session. For more information about your privacy rights, please visit our Privacy Policy.